While some individuals may begin to notice a reduction in hunger within the first week of starting treatment, the full effects typically develop over a period of several weeks
Improving care and promoting health in populations: Standards of Medical Care in Diabetes 2022
A third incretin-based approach is tirzepatide, a dual agonist of GLP-1R and glucose-dependent insulinotropic polypeptide receptor (GIPR), which achieves greater HbA1c reduction and weight loss compared with GLP-1RAs alone
Weight loss Individual to you Reduces blood sugar What included in the Shed Membership
Mller cell gliosis, marked by an increase in glial fibrillary acidic protein (GFAP), can cause excitotoxicity-induced cell death of RGCs [92]
GLP-1 medications are typically administered once weekly via a subcutaneous injection, meaning a small injection just beneath the skin that causes minimal discomfort compared to intramuscular injections